AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
5min chapter
Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's top 2 picks
Investing Experts
Exploring Promising Biotech Investments: Tarsus and SpringWorks
This chapter explores Tarsus Pharmaceuticals and SpringWorks Therapeutics, highlighting Tarsus's drug Xdemvi for demodex blepharitis and SpringWorks's Oxivio for desmoid tumors. The discussion emphasizes the strong market prospects and growth potential of both companies as attractive investment opportunities.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode